Delivery Order SPE2DE24D0013-SPE2D625F1VRV
- Not listed
- The U.S. Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,080 to Cepheid Inc. for COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, issued on August 22, 2025, with completion targeted for August 29, 2025, represents a continuation of the Medical Supply Chain's procurement of molecular diagnostic testing capabilities. Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems and...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,488 firm fixed-price delivery order to Cepheid Inc. on July 30, 2025, for SARS-CoV-2, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. The delivery order, which carries an ultimate completion date of August 13, 2025, will be performed at Cepheid's headquarters in Sunnyvale, California. This award includes no set-aside designation and represents a near-term procurement from the Sunnyvale-based molecular...
- The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $13,980 to Cepheid Inc. for COVID-19/Influenza/RSV diagnostic test kits on August 8, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents procurement of molecular diagnostic testing solutions from the Sunnyvale, California-based manufacturer. The delivery order will be performed at Cepheid's Sunnyvale facility. This...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- This delivery order, awarded on July 24, 2025, represents a $17,680 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain division and Cepheid Inc. for a COVID-19/Influenza/RSV diagnostic kit containing 10 viral tests. The contract is set to be completed by July 31, 2025, with performance taking place at Cepheid's headquarters in Sunnyvale, California. This award is issued without a set-aside designation and falls under Cepheid's existing indefinite delivery...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $17,000 firm fixed-price delivery order to Cepheid Inc. (UEI: W6HQTMWB9Q28) on August 19, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus testing. The contract, designated as XPCOV2/FLU/RSV-10, has an ultimate completion date of August 26, 2025, and will be performed at Cepheid's headquarters in Sunnyvale, California. No small business set-aside was utilized for...
- The Defense Logistics Agency, under its Medical Supply Chain division, awarded a $13,547.30 firm fixed-price delivery order to Cepheid Inc. on August 14, 2025, for respiratory and influenza diagnostic solutions. The contract, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This delivery order carries no set-aside designation and represents procurement under one of Cepheid's existing federal...
- The Defense Logistics Agency's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions, specifically related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The delivery order was executed on August 15, 2025, with an ultimate completion date of August 29, 2025, with performance to be conducted at Cepheid's facility in Sunnyvale, California. No set-aside designation was applied to this contract...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The Defense Logistics Agency's Medical Supply Chain division awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic manufacturer based in Sunnyvale, California, for COVID-19/Influenza/Respiratory Syncytial Virus testing solutions. The delivery order, designated as XPCOV2/FLU/RSV-10, was executed on August 21, 2025, with an ultimate completion date of August 28, 2025, and carries no set-aside designation. This award represents a continuation of Cepheid's...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1VRVDelivery Order
The Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $5,440 to Cepheid Inc. on August 25, 2025, for the supply of COVID-19, influenza, and respiratory syncytial virus (RSV) diagnostic solutions. This firm fixed-price delivery order, which is not set-aside designated, is scheduled for completion by September 2, 2025, and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a continuation of Cepheid's established role as a trusted provider of molecular diagnostic systems and test kits to federal healthcare agencies. This delivery order is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts, most notably the single-award IDV with the Veterans Integrated Service Network 6 valued at $32.8 million through September 2030, or the $2.5 million vehicle with Veterans Integrated Service Network 21, both of which cover PCR testing and molecular diagnostic reagents for infectious diseases including COVID-19, influenza, and RSV. Cepheid's continued work with federal agencies demonstrates the company's established capabilities in supplying GeneXpert diagnostic systems and associated reagents to support critical testing needs across the Department of Veterans Affairs and Defense Health Agency programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 8/25/25 |